A year after infection with the coronavirus, when antibodies in the blood are barely detectable, the immune system continues to “remember” the virus and should respond to some extent upon re-encountering it, a study from China suggests. Researchers studied 141 people infected with the virus in the first half of […]
Read More
The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. METHODS We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2–positive adults […]
Read More
The timing of treatment in relation to vaccination is the strongest predictor of COVID-19 vaccine antibody response say the researchers of a new study. For their study, published in Nature Cancer, researchers from the University of Southampton led a UK multicentre prospective observational study (PROSECO) evaluating COVID-19 vaccine responses in individuals with […]
Read More
The COVID-19 death rate among people who got the Johnson & Johnson vaccine was more than double the rate of other vaccinated Americans during the Omicron wave, according to the latest CDC data. During the week of Jan. 8, coronavirus-related deaths among Johnson & Johnson vaccine recipients reached more than five […]
Read More
Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19. For adults and adolescents eligible for a first booster dose, these shots are safe and provide substantial benefit. During the recent Omicron surge, those who were boosted were […]
Read More
The US Food and Drug Administration (FDA) said Tuesday that it approved fourth doses of COVID-19 vaccines for many Americans to protect the most vulnerable people against severe COVID-19 illness, hospitalization, and death. According to an FDA news release, anyone over 50, and people over 18 who have gotten a solid organ […]
Read More
Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action […]
Read More
Measures to reduce transmission of SARS-CoV-2 have also been effective in reducing the transmission of other endemic respiratory viruses. As many countries decrease the use of such measures, we expect that SARS-CoV-2 will circulate with other respiratory viruses, increasing the probability of co-infections. The clinical outcome of respiratory viral co-infections […]
Read More
Los expertos detrás del estudio afirman que los resultados reafirman la necesidad de vacunarse contra la COVID al igual que contra la gripe. Madrid, 28 de marzo (Europa Press).- Los adultos hospitalizados que tienen COVID-19 y gripe al mismo tiempo corren un riesgo mucho mayor de padecer una enfermedad grave y morir en comparación con los […]
Read More
The Centers for Medicare & Medicaid Services (CMS) now provides data on COVID-19 vaccine booster shots among residents and staff at nursing homes. The data, which feature both completed vaccination and booster rates for individual facilities, is accessible via the Medicare.gov Care Compare website. State and national averages of completed vaccination […]
Read More